Specifically in GC, NPY1R is more highly expressed in the subgroup of gastric tumors presenting MUC16 mutations, and, in agreement with our results, the high expression of NPY1R was associated with dismal prognosis in the GC patients from the TCGA and ACRG cohorts [52]. Here, NPY1R is linked to gastric neoplasm.